哺乳动物雷帕霉素靶蛋白抑制药的心血管作用研究进展
摘要
哺乳动物雷帕霉素靶蛋白（mammalian target of rapamycin，mTOR）是一种非典型的丝氨酸／苏氨酸激酶，属于磷酯酰肌醇3激酶相关激酶（phosphatidylinositol kinase—related kinases，PIKKs）家族。mTOR抑制药已上市的有雷帕霉素（Rapamycin／Sirolimus，RAP）及依维莫司（Everolimus，RAD001），主要用于器官移植的抗排异反应。
出处
《中国药师》
CAS
2009年第1期54-56,共3页
China Pharmacist
基金
南京军区医学科学技术研究"十一五"计划课题(06MA154)
福建省中医药科研项目(WZY0621)
参考文献33
-
1李志雄,唐礼功,潘铁军,饶作祥,谢森,李志强.肾移植术后应用雷帕霉素抗排斥治疗16例分析[J].中国药师,2006,9(10):943-945. 被引量：2
-
2Drenan RM, Liu X, Bertram PG, et al. FKBP12-rapamycin-associated protein or mammalian target of rapamycin (FRAP/mTOR) localization in the endoplasmic reticulum and the Golgi apparatus [ J ]. J Biol Chem,2004,279 C 1 ) :772- 778.
-
3Veverka V, Crabbe T, Bird I, et al. Structural characterization of the interaction of roTOR with phosphatidic acid and a novel class of inhibitor: compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTOR[J]. Oncogene,2008,27(5) :585-595.
-
4Sato T, Umetsu A, Tamanoi F. Characterization of the Rheb-mTOR signaling pathway in mammalian cells: constitutive active mutants of Rheb and mTOR [ J ]. Methods Enzymol, 2008,438 : 307 -320.
-
5Soulard A, Hall MN. SnapShot : mTOR signaling [ J ]. Cell,2007,129 (2) :434.
-
6LoPiccolo J, Blumentbal GM, Bernstein WB, et al. Targeting the PI3K/Akt/ mTOR pathway: effective combinalions and clinical considerations [ J ]. Drug Resist Updat ,2008,11 ( 1-2 ) :32-50.
-
7Parahuleva MS, Kanse SM, Parviz B, et al. Factor Seven Activating Protease (FSAP) expression in human monocytes and accumulation in unstable coronary atherosclerotic plaques [ J ]. Atherosclerosis . 2008,196 ( 1 ) : 164-171.
-
8Zargham R. Preventing restenosis after angioplasty : a multistage approach [ J ]. Clin Sci ( Lond ) , 2008,114 (4) :257 -264.
-
9Chen XL, Chen ZS, Ding Z, et al. Antisense extracellular signal-regulated kinase-2 gene therapy inhibits platelei-derived growth factor-induced proliferation, migration and transfoiTning growth factor-β1 expression in vascular smooth muscle cells and attenuates transplant vasculopathy [ J ]. Transplant Int, 2008,21 ( 1 ) : 30-38.
-
10Marx SO, Jayaraman T, Go LO, et al. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle ceils [ J ]. Circ Res, 1995, 76(3) :412-417.
二级参考文献8
-
1Gummert JF,Ikonen T,Morris RE.Newer immunosuppressive drugs:a review[J].JAm Soc Nephrol,1999,10:1366-1380
-
2Sehgal SN.Rapamune (RAPA,rapamycin,sirolimus):mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression[J].Clin Biochem,1998,31(5):335-340
-
3Andoh TF,Lindsley J,Franceschini N,et al.Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model[J].Transplantion,1996,62(3):311-316
-
4Groth CG,Backman L,Morales JM,et al.Sirolimus (rapamycin) based therapy in human renal transplantation.Similar efficacy and different toxicity compared with cyclosporine[J].Transplantation,1999,67(7):1036-1043
-
5Sedrani R,Cottenss,Kallen J,et al.Chemical modification of rapamycin:the discovery of SDZ RAD[J].Transplant Proc,1998.30:2192-2194
-
6Liu KL,Chu SH,Chiang YJ.Sirolimus reduces the incidence of acute rejection episodes in renal transplantion:an initial experience in Taiwan[J].Transplant Proc,2004,36 (7):2051-2052
-
7Boletis J,Balitsari A,Filiopoulos V,et al.Delayed renal graft function:the influence of immunosuppression[J].Transplant-Proc,2005,37(5):2054-2059
-
8Kuypers DR.Benefitrisk assessment of sirolimus in renal transplantion[J].Drug Saf,2005,28(2):153-181
-
1Jochen Klupp Jan Michael Langrehr 等.mTOR抑制剂新一类免疫抑制剂[J].德国临床用药,2001,4(4):17-19.
-
2戴润成.西比灵配合双氯酚酸钠治疗血管性头痛的疗效观察[J].河北医学,2002,8(1):74-75.
-
3王剑.相关基因的遗传多态性对他克莫司疗效的影响[J].实用医药杂志,2015,32(1):75-78. 被引量：1
-
4欧洲委员会批准诺华公司的Afinitor用于肾细胞癌患者[J].中国新药杂志,2009,18(19):1818-1818.
-
5欧洲委员会批准诺华公司的Afinitor用于肾细胞癌患者[J].中国新药杂志,2009,18(19):1817-1817.
-
6苏凤云,刘爱军,苏定冯.西罗莫司的药理学作用研究进展[J].药学实践杂志,2011,29(5):336-338. 被引量：7
-
7黄永城.新型免疫抑制剂Sirolimus[J].药学进展,2000,24(1):52-53.
-
8欧盟建议批准诺华公司的Afinitor用于治疗晚期肾癌患者[J].中国新药杂志,2009,18(13):1180-1180.
-
9何艳,童汉云,辛华雯,余爱荣,李罄,郭珩.肾移植后恶性肿瘤的研究进展[J].医药导报,2012,31(1):29-32. 被引量：3
-
10张梦莎,孙铁民.依维莫司(everolimus)[J].中国药物化学杂志,2010,20(6):553-554. 被引量：2
